
According to Benzinga Pro, during Q4, Selecta Biosciences (NASDAQ:SELB) earned $12.24 million, a 168.4% increase from the preceding quarter. Selecta Biosciences also posted a total of $29.94 million in sales, a 22.56% increase since Q3. In Q3, Selecta Biosciences brought in $24.43 million in sales but lost $17.89 million in earnings.